Philip Halverson is a Rheumatology/Immunology physician affiliated with Clinical Research Institute. OpenAlex indexes 14 publications with 273 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Nicollet Mall
Suite 1149
Minneapolis, MN 554022606
Telephone
612-338-3333Registry record last updated 2 Feb 2010.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ALK-Abello, IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
90.5%Corticosteroid45.6%Breo Ellipta26%Symbicort23%Fluticasone Propionate15%Trelegy Ellipta11%Mometasone Furoate10%Qvar Redihaler10%Flovent Hfa6%Part D<11 patientsLeukotriene Receptor Antagonist20%Montelukast Sodium100%Part D≥28 patients+ 2 more classes in this area
Metabolism & gastrointestinal
6.5%Corticosteroid6.5%Prednisone100%Part D≥17 patientsNervous system
3%Tricyclic Antidepressant3%Doxepin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
Headache The Journal of Head and Face Pain
2020 - The evaluation of the correct use and ease‐of use of the ELLIPTA DPI in children with asthma
Pediatric Pulmonology
2020 - Practical use of Ellipta, a once-daily, dry powder inhaler for children with asthma
Journal of Allergy and Clinical Immunology
2020 - A Novel Breath Actuated Device (Autohaler™) Consistently Actuates During the Early Phase of Inspiration
Journal of Aerosol Medicine
1995
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”